跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AKI-2
首页
药物
AKI-2
AKI-2
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
{4-[5-(3-chloro-phenoxy)-oxazolo[5,4-d]pyrimidin-2-yl]-2,6-dimethyl-phenoxy}-acetic acid for use in the prevention or treatment of acute kidney injury
US 9782411 B2
申请人: SANOFI SA
优先权: 2013
CN
EP
US
3 件公开
Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
CN 101257903 A
申请人: BAYER HEALTHCARE AG
优先权: 2005
CN
Combination therapy comprising a diaryl urea compound and a p13, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
US 2009192127 A1
申请人: BAYER HEALTHCARE AG
优先权: 2006
US
Methods and compositions for assigning likelihood of acute kidney injury progression
CN 103826662 A
申请人: ALERE SAN DIEGO INC
优先权: 2012
CN
Beverage for treating kidney deficiency
CN 105614596 A
申请人: ZHANG ZENGHUI
优先权: 2014
CN
Traditional Chinese medicine composition for treating ovarian failure
CN 105362672 A
申请人: ZHENGZHOU ZHENGXIAN PHARMACEUTICAL TECH CO LTD
优先权: 2015
CN
USE OF ANTIBODIES TO TIMP-2 FOR THE IMPROVEMENT OF RENAL FUNCTION
CN 110352073 A
申请人: ASTUTE MEDICAL INC
优先权: 2016
CN
一种过表达ZEB2基因质粒及其构建方法和应用
CN 107119072 B
申请人: 安徽医科大学
优先权: 2017
CN
Preparation process of folium artemisiae argyi extract and application of folium artemisiae argyi extract in preparation of acute kidney injury medicines
CN 110859864 A
申请人: JIANGSU FOOD & PHARMACEUTICAL SCIENCE COLLEGE
优先权: 2019
CN
STABLE PEPTIDE WITH RENAL ENZYMATIC ACTIVITY
CN 116157140 A
申请人: BESO PHARMA LLC
优先权: 2020
CN
第 1 / 4 页
上一页
下一页
药物
反馈